PMC:7205724 / 656-902 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"55","span":{"begin":37,"end":43},"obj":"Species"},{"id":"56","span":{"begin":128,"end":136},"obj":"Species"},{"id":"57","span":{"begin":194,"end":203},"obj":"Species"},{"id":"58","span":{"begin":235,"end":243},"obj":"Species"},{"id":"65","span":{"begin":9,"end":22},"obj":"Disease"},{"id":"66","span":{"begin":24,"end":32},"obj":"Disease"},{"id":"67","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"68","span":{"begin":152,"end":160},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"Tax:9606"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:9606"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:2697049"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:9606"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D034062"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:C000657245"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C000657245"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":116,"end":122},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":24,"end":32},"obj":"Disease"},{"id":"T8","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"T9","span":{"begin":152,"end":160},"obj":"Disease"},{"id":"T10","span":{"begin":194,"end":198},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":37,"end":43},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T3","span":{"begin":116,"end":122},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T4","span":{"begin":204,"end":207},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":15,"end":22},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T7","span":{"begin":24,"end":32},"obj":"Species"},{"id":"T8","span":{"begin":37,"end":43},"obj":"Species"},{"id":"T9","span":{"begin":106,"end":114},"obj":"Species"},{"id":"T10","span":{"begin":152,"end":160},"obj":"Species"},{"id":"T11","span":{"begin":194,"end":203},"obj":"Species"}],"attributes":[{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:2697049"},{"id":"A8","pred":"ncbi_taxonomy_id","subj":"T8","obj":"NCBItxid:9605"},{"id":"A9","pred":"ncbi_taxonomy_id","subj":"T9","obj":"NCBItxid:2697049"},{"id":"A10","pred":"ncbi_taxonomy_id","subj":"T10","obj":"NCBItxid:2697049"},{"id":"A11","pred":"ncbi_taxonomy_id","subj":"T11","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T12","span":{"begin":45,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"65","span":{"begin":9,"end":22},"obj":"Disease"},{"id":"66","span":{"begin":24,"end":32},"obj":"Disease"},{"id":"55","span":{"begin":37,"end":43},"obj":"Species"},{"id":"67","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"56","span":{"begin":128,"end":136},"obj":"Species"},{"id":"68","span":{"begin":152,"end":160},"obj":"Disease"},{"id":"57","span":{"begin":194,"end":203},"obj":"Species"},{"id":"58","span":{"begin":235,"end":243},"obj":"Species"}],"attributes":[{"id":"A56","pred":"pubann:denotes","subj":"56","obj":"Tax:9606"},{"id":"A66","pred":"pubann:denotes","subj":"66","obj":"MESH:C000657245"},{"id":"A67","pred":"pubann:denotes","subj":"67","obj":"MESH:C000657245"},{"id":"A58","pred":"pubann:denotes","subj":"58","obj":"Tax:9606"},{"id":"A68","pred":"pubann:denotes","subj":"68","obj":"MESH:C000657245"},{"id":"A57","pred":"pubann:denotes","subj":"57","obj":"Tax:2697049"},{"id":"A65","pred":"pubann:denotes","subj":"65","obj":"MESH:D034062"},{"id":"A55","pred":"pubann:denotes","subj":"55","obj":"Tax:9606"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T102","span":{"begin":9,"end":14},"obj":"JJ"},{"id":"T103","span":{"begin":15,"end":22},"obj":"NN"},{"id":"T104","span":{"begin":22,"end":23},"obj":"-COMMA-"},{"id":"T105","span":{"begin":24,"end":32},"obj":"NN"},{"id":"T106","span":{"begin":32,"end":33},"obj":"-COMMA-"},{"id":"T107","span":{"begin":34,"end":36},"obj":"IN"},{"id":"T108","span":{"begin":37,"end":43},"obj":"NNS"},{"id":"T109","span":{"begin":45,"end":49},"obj":"RB"},{"id":"T110","span":{"begin":49,"end":50},"obj":"-COMMA-"},{"id":"T111","span":{"begin":51,"end":53},"obj":"PRP"},{"id":"T112","span":{"begin":54,"end":58},"obj":"MD"},{"id":"T113","span":{"begin":59,"end":66},"obj":"VB"},{"id":"T114","span":{"begin":67,"end":69},"obj":"DT"},{"id":"T115","span":{"begin":70,"end":78},"obj":"NN"},{"id":"T116","span":{"begin":79,"end":81},"obj":"IN"},{"id":"T117","span":{"begin":82,"end":93},"obj":"JJ"},{"id":"T118","span":{"begin":94,"end":101},"obj":"NNS"},{"id":"T119","span":{"begin":102,"end":105},"obj":"IN"},{"id":"T120","span":{"begin":106,"end":114},"obj":"NN"},{"id":"T121","span":{"begin":116,"end":122},"obj":"NN"},{"id":"T122","span":{"begin":123,"end":127},"obj":"IN"},{"id":"T123","span":{"begin":128,"end":136},"obj":"NNS"},{"id":"T124","span":{"begin":137,"end":146},"obj":"VBN"},{"id":"T125","span":{"begin":147,"end":151},"obj":"IN"},{"id":"T126","span":{"begin":152,"end":160},"obj":"NN"},{"id":"T127","span":{"begin":161,"end":165},"obj":"WDT"},{"id":"T128","span":{"begin":166,"end":174},"obj":"VBZ"},{"id":"T129","span":{"begin":175,"end":185},"obj":"NNS"},{"id":"T130","span":{"begin":186,"end":193},"obj":"IN"},{"id":"T131","span":{"begin":194,"end":203},"obj":"NN"},{"id":"T132","span":{"begin":204,"end":207},"obj":"VBZ"},{"id":"T133","span":{"begin":208,"end":213},"obj":"VBN"},{"id":"T134","span":{"begin":214,"end":223},"obj":"JJ"},{"id":"T135","span":{"begin":224,"end":231},"obj":"NNS"},{"id":"T136","span":{"begin":232,"end":234},"obj":"IN"},{"id":"T137","span":{"begin":235,"end":243},"obj":"NNS"}],"relations":[{"id":"R96","pred":"arg1Of","subj":"T103","obj":"T102"},{"id":"R97","pred":"arg1Of","subj":"T103","obj":"T104"},{"id":"R98","pred":"arg2Of","subj":"T105","obj":"T104"},{"id":"R101","pred":"arg2Of","subj":"T108","obj":"T107"},{"id":"R102","pred":"arg1Of","subj":"T113","obj":"T109"},{"id":"R103","pred":"arg1Of","subj":"T113","obj":"T110"},{"id":"R104","pred":"arg1Of","subj":"T111","obj":"T112"},{"id":"R105","pred":"arg2Of","subj":"T113","obj":"T112"},{"id":"R106","pred":"arg1Of","subj":"T111","obj":"T113"},{"id":"R107","pred":"arg2Of","subj":"T115","obj":"T113"},{"id":"R108","pred":"arg1Of","subj":"T115","obj":"T114"},{"id":"R109","pred":"arg1Of","subj":"T115","obj":"T116"},{"id":"R110","pred":"arg2Of","subj":"T118","obj":"T116"},{"id":"R111","pred":"arg1Of","subj":"T118","obj":"T117"},{"id":"R112","pred":"arg1Of","subj":"T115","obj":"T119"},{"id":"R113","pred":"arg2Of","subj":"T120","obj":"T119"},{"id":"R114","pred":"arg1Of","subj":"T121","obj":"T122"},{"id":"R115","pred":"arg2Of","subj":"T123","obj":"T122"},{"id":"R116","pred":"arg2Of","subj":"T123","obj":"T124"},{"id":"R117","pred":"arg1Of","subj":"T124","obj":"T125"},{"id":"R118","pred":"arg2Of","subj":"T126","obj":"T125"},{"id":"R119","pred":"arg1Of","subj":"T126","obj":"T127"},{"id":"R120","pred":"arg1Of","subj":"T126","obj":"T128"},{"id":"R121","pred":"arg2Of","subj":"T129","obj":"T128"},{"id":"R122","pred":"arg1Of","subj":"T129","obj":"T130"},{"id":"R123","pred":"arg2Of","subj":"T131","obj":"T130"},{"id":"R124","pred":"arg1Of","subj":"T121","obj":"T132"},{"id":"R125","pred":"arg2Of","subj":"T133","obj":"T132"},{"id":"R126","pred":"arg1Of","subj":"T121","obj":"T133"},{"id":"R127","pred":"arg2Of","subj":"T135","obj":"T133"},{"id":"R128","pred":"arg1Of","subj":"T135","obj":"T134"},{"id":"R129","pred":"arg1Of","subj":"T133","obj":"T136"},{"id":"R130","pred":"arg2Of","subj":"T137","obj":"T136"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":116,"end":122},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T7","span":{"begin":24,"end":32},"obj":"Disease"},{"id":"T8","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"T9","span":{"begin":152,"end":160},"obj":"Disease"},{"id":"T10","span":{"begin":194,"end":203},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":45,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"entially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients wi"}